首頁 > 市場調查報告書 > 製藥

感染疾病

市場調查報告書

商品編碼

1468201

2024-2032 年按類型、給藥途徑（局部、口服、靜脈注射等）、配銷通路和地區分類的抗感染藥市場報告

Anti-infectives Market Report by Type, Route of Administration (Topical, Oral, Intravenous, and Others), Distribution Channel, and Region 2024-2032

出版日期: 2024年04月08日 | 出版商:

IMARC | 英文 137 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

IMARC Group年全球抗感染藥物市場規模達1,347億美元。

抗感染藥物是一種透過抑制傳播或徹底殺死傳染源來對抗感染的藥物。這些藥物包括抗生素、抗病毒藥、抗黴菌藥、抗瘧藥、驅蟲藥和抗原蟲藥。它們通常透過口服、腸胃外和局部途徑施用。它們廣泛用於治療肺炎和結核病等輕微傳染病。除此之外，在常規程序和手術中也會使用抗感染藥物，例如剖腹產和關節置換，這些都與嚴重感染的高風險有關。

抗感染藥物市場趨勢：

全球抗感染藥物市場主要是由全球傳染病發生率上升所推動的。反不定式用於治療感染，包括病毒、細菌、寄生蟲和真菌。此外，使用不同策略配製的新藥的開發，例如天然產物、群體感應抑製劑、生物膜破壞劑、鎵基藥物、環糊精抑製劑和光基抗菌劑，正在為市場成長提供動力。與此一致的是，藥物發現程序的最新創新，例如幹細胞和器官晶片（OOC）技術，旨在增強藥物試驗過程，正在為市場創造積極的前景。此外，由於 COVID-19 疾病和誘發感染（如麴菌病、侵襲性念珠菌病和毛黴菌病）的出現，產品採用率不斷增加，正在加強市場的成長。除此之外，越來越多的新型抗感染藥物獲得監管機構批准也是另一個成長誘導因素。此外，有利的政府政策的實施、對開發新藥和創新藥物的投資增加、個人對傳染病的認知提高以及醫療基礎設施的迅速改善預計將推動未來幾年市場的成長。

本報告回答的關鍵問題

2023年全球抗感染藥物市場規模有多大？
2024-2032年全球抗感染藥物市場的預期成長率是多少？
推動全球抗感染藥物市場的關鍵因素是什麼？
COVID-19 對全球抗感染藥物市場有何影響？
全球抗感染藥物市場按類型分類是怎樣的？
根據給藥途徑，全球抗感染藥物市場的細分如何？
基於配銷通路的全球抗感染藥物市場的詳細情形如何？
全球抗感染藥物市場的重點區域有哪些？
全球抗感染藥物市場的主要參與者/公司有哪些？

Anti-infectives are medicines that act against infections, either by inhibiting the spread or killing the infectious agent outright. These medicines include antibiotics, antivirals, antifungals, antimalarials, anthelmintics, and antiprotozoals. They are generally administered through oral, parenteral, and topical routes. They are widely used to treat minor infectious diseases, including pneumonia and tuberculosis. Apart from this, anti-infectives are also utilized during routine procedures and surgeries, such as cesarian section and joint replacement, which are associated with a high risk of severe infection.

Anti-infectives Market Trends:

The global anti-infectives market is primarily driven by rising incidences of infectious diseases across the globe. Anti-Infinitives are used to treat infections, including viruses, bacteria, parasites, and fungi. Additionally, the development of novel drugs that are formulated using different strategies, such as natural products, quorum sensing inhibitors, biofilm disruptors, gallium-based drugs, cyclodextrin inhibitors, and light-based antimicrobials, are providing an impetus to the market growth. In line with this, the latest innovations in drug discovery procedures, such as stem cells and organ-on-chip (OOC) technologies, to enhance drug trial processes are creating a positive outlook for the market. Furthermore, the increasing product adoption due to the advent of the COVID-19 disease and induced infections, such as aspergillosis, invasive candidiasis, and mucormycosis, is strengthening the growth of the market. Besides this, the increasing number of new anti-infective drugs being approved by the regulatory authorities is acting as another growth-inducing factor. Moreover, the implementation of favorable government policies, rising investments in developing new and innovative drugs, increasing awareness among individuals about infectious diseases, and rapidly improving healthcare infrastructure are anticipated to impel the growth of the market in the coming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global anti-infectives market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, route of administration and distribution channel.

Breakup by Type:

Antibacterial

Antifungal

Antiviral

Breakup by Route of Administration:

Topical

Oral

Intravenous (IV)

Others

Breakup by Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Speciality Pharmacies

Online Stores

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Cipla Health Ltd. (Cipla Limited), F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Glenmark Pharmaceuticals Limited, Johnson & Johnson, Lupin Limited, Sandoz AG (Novartis AG) and Sun Pharmaceutical Industries Limited.

Key Questions Answered in This Report

1. What was the size of the global anti-infectives market in 2023?
2. What is the expected growth rate of the global anti-infectives market during 2024-2032?
3. What are the key factors driving the global anti-infectives market?
4. What has been the impact of COVID-19 on the global anti-infectives market?
5. What is the breakup of the global anti-infectives market based on the type?
6. What is the breakup of the global anti-infectives market based on the route of administration?
7. What is the breakup of the global anti-infectives market based on distribution channel?
8. What are the key regions in the global anti-infectives market?
9. Who are the key players/companies in the global anti-infectives market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Anti-infectives Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Type

6.1 Antibacterial
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Antifungal
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Antiviral
- 6.3.1 Market Trends
- 6.3.2 Market Forecast

7 Market Breakup by Route of Administration

7.1 Topical
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Oral
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Intravenous (IV)
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Others
- 7.4.1 Market Trends
- 7.4.2 Market Forecast

8 Market Breakup by Distribution Channel

8.1 Hospital Pharmacies
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Retail Pharmacies
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Speciality Pharmacies
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Online Stores
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
8.5 Others
- 8.5.1 Market Trends
- 8.5.2 Market Forecast

9 Market Breakup by Region

9.1 North America
- 9.1.1 United States
  - 9.1.1.1 Market Trends
  - 9.1.1.2 Market Forecast
- 9.1.2 Canada
  - 9.1.2.1 Market Trends
  - 9.1.2.2 Market Forecast
9.2 Asia-Pacific
- 9.2.1 China
  - 9.2.1.1 Market Trends
  - 9.2.1.2 Market Forecast
- 9.2.2 Japan
  - 9.2.2.1 Market Trends
  - 9.2.2.2 Market Forecast
- 9.2.3 India
  - 9.2.3.1 Market Trends
  - 9.2.3.2 Market Forecast
- 9.2.4 South Korea
  - 9.2.4.1 Market Trends
  - 9.2.4.2 Market Forecast
- 9.2.5 Australia
  - 9.2.5.1 Market Trends
  - 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
  - 9.2.6.1 Market Trends
  - 9.2.6.2 Market Forecast
- 9.2.7 Others
  - 9.2.7.1 Market Trends
  - 9.2.7.2 Market Forecast
9.3 Europe
- 9.3.1 Germany
  - 9.3.1.1 Market Trends
  - 9.3.1.2 Market Forecast
- 9.3.2 France
  - 9.3.2.1 Market Trends
  - 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
  - 9.3.3.1 Market Trends
  - 9.3.3.2 Market Forecast
- 9.3.4 Italy
  - 9.3.4.1 Market Trends
  - 9.3.4.2 Market Forecast
- 9.3.5 Spain
  - 9.3.5.1 Market Trends
  - 9.3.5.2 Market Forecast
- 9.3.6 Russia
  - 9.3.6.1 Market Trends
  - 9.3.6.2 Market Forecast
- 9.3.7 Others
  - 9.3.7.1 Market Trends
  - 9.3.7.2 Market Forecast
9.4 Latin America
- 9.4.1 Brazil
  - 9.4.1.1 Market Trends
  - 9.4.1.2 Market Forecast
- 9.4.2 Mexico
  - 9.4.2.1 Market Trends
  - 9.4.2.2 Market Forecast
- 9.4.3 Others
  - 9.4.3.1 Market Trends
  - 9.4.3.2 Market Forecast
9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast

10 SWOT Analysis

10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
- 14.3.1 Abbott Laboratories
  - 14.3.1.1 Company Overview
  - 14.3.1.2 Product Portfolio
  - 14.3.1.3 Financials
  - 14.3.1.4 SWOT Analysis
- 14.3.2 Cipla Health Ltd. (Cipla Limited)
  - 14.3.2.1 Company Overview
  - 14.3.2.2 Product Portfolio
- 14.3.3 F. Hoffmann-La Roche AG
  - 14.3.3.1 Company Overview
  - 14.3.3.2 Product Portfolio
  - 14.3.3.3 Financials
- 14.3.4 GlaxoSmithKline plc
  - 14.3.4.1 Company Overview
  - 14.3.4.2 Product Portfolio
  - 14.3.4.3 Financials
  - 14.3.4.4 SWOT Analysis
- 14.3.5 Glenmark Pharmaceuticals Limited
  - 14.3.5.1 Company Overview
  - 14.3.5.2 Product Portfolio
  - 14.3.5.3 Financials
  - 14.3.5.4 SWOT Analysis
- 14.3.6 Johnson & Johnson
  - 14.3.6.1 Company Overview
  - 14.3.6.2 Product Portfolio
  - 14.3.6.3 Financials
  - 14.3.6.4 SWOT Analysis
- 14.3.7 Lupin Limited
  - 14.3.7.1 Company Overview
  - 14.3.7.2 Product Portfolio
  - 14.3.7.3 Financials
  - 14.3.7.4 SWOT Analysis
- 14.3.8 Sandoz AG (Novartis AG)
  - 14.3.8.1 Company Overview
  - 14.3.8.2 Product Portfolio
- 14.3.9 Sun Pharmaceutical Industries Limited
  - 14.3.9.1 Company Overview
  - 14.3.9.2 Product Portfolio
  - 14.3.9.3 Financials
  - 14.3.9.4 SWOT Analysis

簡介目錄圖表

List of Figures

Figure 1: Global: Anti-infectives Market: Major Drivers and Challenges
Figure 2: Global: Anti-infectives Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Anti-infectives Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Anti-infectives Market: Breakup by Type (in %), 2023
Figure 5: Global: Anti-infectives Market: Breakup by Route of Administration (in %), 2023
Figure 6: Global: Anti-infectives Market: Breakup by Distribution Channel (in %), 2023
Figure 7: Global: Anti-infectives Market: Breakup by Region (in %), 2023
Figure 8: Global: Anti-infectives (Antibacterial) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Anti-infectives (Antibacterial) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Anti-infectives (Antifungal) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Anti-infectives (Antifungal) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Anti-infectives (Antiviral) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Anti-infectives (Antiviral) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Anti-infectives (Topical) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Anti-infectives (Topical) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Anti-infectives (Oral) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Anti-infectives (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Anti-infectives (Intravenous (IV)) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Anti-infectives (Intravenous (IV)) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Anti-infectives (Others) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Anti-infectives (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Anti-infectives (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Anti-infectives (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Anti-infectives (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Anti-infectives (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Global: Anti-infectives (Speciality Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: Anti-infectives (Speciality Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Global: Anti-infectives (Online Stores) Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Global: Anti-infectives (Online Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Global: Anti-infectives (Other Distribution Channels) Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Global: Anti-infectives (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: North America: Anti-infectives Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: North America: Anti-infectives Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: United States: Anti-infectives Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: United States: Anti-infectives Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: Canada: Anti-infectives Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: Canada: Anti-infectives Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: Asia-Pacific: Anti-infectives Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: Asia-Pacific: Anti-infectives Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: China: Anti-infectives Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: China: Anti-infectives Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: Japan: Anti-infectives Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: Japan: Anti-infectives Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: India: Anti-infectives Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: India: Anti-infectives Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: South Korea: Anti-infectives Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: South Korea: Anti-infectives Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: Australia: Anti-infectives Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: Australia: Anti-infectives Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: Indonesia: Anti-infectives Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: Indonesia: Anti-infectives Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: Others: Anti-infectives Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: Others: Anti-infectives Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: Europe: Anti-infectives Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: Europe: Anti-infectives Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Germany: Anti-infectives Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Germany: Anti-infectives Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: France: Anti-infectives Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: France: Anti-infectives Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: United Kingdom: Anti-infectives Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: United Kingdom: Anti-infectives Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Italy: Anti-infectives Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Italy: Anti-infectives Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Spain: Anti-infectives Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Spain: Anti-infectives Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Russia: Anti-infectives Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Russia: Anti-infectives Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Others: Anti-infectives Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Others: Anti-infectives Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Latin America: Anti-infectives Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Latin America: Anti-infectives Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: Brazil: Anti-infectives Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: Brazil: Anti-infectives Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: Mexico: Anti-infectives Market: Sales Value (in Million US$), 2018 & 2023
Figure 75: Mexico: Anti-infectives Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 76: Others: Anti-infectives Market: Sales Value (in Million US$), 2018 & 2023
Figure 77: Others: Anti-infectives Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 78: Middle East and Africa: Anti-infectives Market: Sales Value (in Million US$), 2018 & 2023
Figure 79: Middle East and Africa: Anti-infectives Market: Breakup by Country (in %), 2023
Figure 80: Middle East and Africa: Anti-infectives Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 81: Global: Anti-infectives Industry: SWOT Analysis
Figure 82: Global: Anti-infectives Industry: Value Chain Analysis
Figure 83: Global: Anti-infectives Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Anti-infectives Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Anti-infectives Market Forecast: Breakup by Type (in Million US$), 2024-2032
Table 3: Global: Anti-infectives Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
Table 4: Global: Anti-infectives Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
Table 5: Global: Anti-infectives Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Anti-infectives Market: Competitive Structure
Table 7: Global: Anti-infectives Market: Key Players

02-2729-4219

+886-2-2729-4219